The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead 2vt Regulatory News (BMD)

Share Price Information for Baronsmead 2vt (BMD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 55.50
Bid: 54.00
Ask: 57.00
Change: 2.50 (4.50%)
Spread: 3.00 (5.556%)
Open: 55.50
High: 58.00
Low: 58.00
Prev. Close: 55.50
BMD Live PriceLast checked at -
Baronsmead Second Venture Trust is an Investment Trust

To achieve long-term investment returns for private investors by investing primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of New Shares

23 Jan 2020 11:45

RNS Number : 7499A
Baronsmead Second Venture Trust PLC
23 January 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

Baronsmead Second Venture Trust plc

23 January 2020

Issue of New Shares pursuant to the Offer for Subscription

The Board of Baronsmead Second Venture Trust plc (the "Company") announced on 4 October 2019 that it had published a prospectus in conjunction with Baronsmead Venture Trust plc in relation to an offer for subscription to each raise up to £20 million in aggregate (before costs) with an over-allotment facility to each raise up to a further £5 million in aggregate (the "Offer"). The Company announced on 20 November 2019 that 11,596,119 New Shares would be issued at an issue price of 78.90 pursuant to the first allotment under the Offer.

In accordance with its discretion under the Prospectus, the Company further announced on 13 December 2019 that the date of the second allotment under the Offer had been amended and is to take place on 24 January 2020. Accordingly, New Shares in the Company issued under the second allotment of the Offer will be issued at an issue price of 84.80 pence and 5,978,704 New Shares in aggregate will be issued pursuant to the second allotment of the Offer. The issue price has been calculated by dividing the Company's latest published Net Asset Value of 82.40 pence per ordinary share as at 31 December 2019 by 0.9725 in accordance with the terms of the Offer.

Applications have been made for the New Shares to be issued pursuant to the Offer to be admitted to the Official List (with a Premium Listing) and to the London Stock Exchange for the New Shares to be admitted to trading on the Main Market. It is expected that Admission will occur and dealing will commence in the New Shares to be issued pursuant to the Offer at 8.00 a.m. on 24 January 2020.

It is expected that share certificates in respect of the New Shares will be issued to the relevant Shareholders within 10 business days of the date of the second allotment.

Over Allotment Facility

Following the second allotment of shares under the Offer the Company has raised approximately £14.5 million. Following discussions with its advisers the Board has resolved to approve the use of the Company's Over Allotment Facility to raise an additional £5 million under the Offer.

Total voting rights

Each Ordinary Share has one voting right. Following the issue of New Shares pursuant to the Offer, the Company will have 265,595,151 Ordinary Shares in issue (of which 22,250,063 Ordinary Shares are held in treasury). The total number of voting rights in the Company will therefore be 243,345,088 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

Further information

For further information please contact.

Baronsmead VCT Investor Relations

020 3875 9862

baronsmeadvcts@greshamhouse.com

 Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

The issue and the distribution of this announcement and the Prospectus in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to in this announcement and the Prospectus comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEBJMBTMTJTBFM
Date   Source Headline
11th Aug 20096:02 pmPRNNet Asset Value(s)
11th Aug 20095:54 pmPRNHalf-yearly Report
11th Aug 20093:13 pmPRNAppointment of a broker
4th Aug 20095:33 pmPRNDirectorate Appointment
4th Jun 20095:02 pmRNSNet Asset Value(s)
21st May 20094:03 pmRNSTransaction in Own Shares
15th May 20093:34 pmRNSNet Asset Value(s)
15th May 200912:45 pmRNSInterim Management Statement
7th Apr 200912:56 pmRNSClose of Offer
6th Apr 20099:28 amRNSOffer and Allotment of shares
27th Mar 20094:14 pmRNSTransaction in Own Shares
27th Mar 20099:24 amRNSDirector/PDMR Shareholding
27th Mar 20099:24 amRNSDirector/PDMR Shareholding
26th Mar 200911:31 amRNSNet Asset Value & Offer Update
18th Mar 20092:38 pmRNSAGM Statement
11th Mar 20099:38 amRNSNet Asset Value(s)
23rd Feb 200912:30 pmRNSAnnual Information Update
11th Feb 20094:23 pmRNSNet Asset Value(s)
11th Feb 20094:23 pmRNSFinal Results
11th Dec 20083:55 pmRNSNet Asset Value(s)
2nd Dec 20083:38 pmRNSShare buy back
1st Dec 20083:34 pmRNSAppointment of Broker
12th Nov 20083:34 pmRNSInterim Management Statement
30th Sep 20083:04 pmRNSTransaction in Own Shares - Share buy back
25th Sep 200811:00 amRNSEGM Statement
9th Sep 20089:23 amRNSEGM Statement - Circular with
4th Sep 20084:26 pmRNSNet Asset Value(s)
28th Aug 200811:02 amRNSInterim Results Document with
13th Aug 200812:40 pmRNSInterim Results - amendment t
13th Aug 200811:12 amRNSNet Asset Value(s)
13th Aug 20087:00 amRNSInterim Results
16th Jul 20083:40 pmRNSDirector Declaration
6th Jun 20083:32 pmRNSNet Asset Value(s)
22nd May 20082:46 pmRNSTransaction in Own Shares
14th May 200811:50 amRNSNet Asset Value(s)
14th May 200811:49 amRNSInterim Management Statement
1st Apr 20081:47 pmRNSTransaction in Own Shares
19th Mar 20083:58 pmRNSAGM Statement
19th Mar 20083:27 pmRNSTransaction in Own Shares
14th Mar 20082:28 pmRNSNet Asset Value(s)
25th Feb 20083:41 pmRNSIssue of Equity
13th Feb 20084:24 pmRNSNet Asset Value(s)
6th Feb 200811:54 amRNSAnnual Information Update
6th Feb 200811:52 amRNSIssue of Equity
6th Feb 200811:48 amRNSAnnual Report and Accounts
4th Feb 20083:23 pmRNSDirector/PDMR Shareholding
4th Feb 20083:21 pmRNSDirector/PDMR Shareholding
4th Feb 20083:19 pmRNSDirector/PDMR Shareholding
28th Jan 20082:35 pmRNSAdditional Listing
28th Jan 20082:31 pmRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.